Featured News
672Wire StoriesLaurentian Bank Financial Group reports second quarter 2021 results
The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April 30, 2021, and...
- 796Wire Stories
Laurentian Bank Financial Group reports second quarter 2021 results
The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April 30, 2021, and...
- 643Wire Stories
Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Osimertinib Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Osimertinib is a small molecule targeted...
- 745Wire Stories
Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Osimertinib Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Osimertinib is a small molecule targeted...
- 772Wire Stories
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac®,...
- 733Wire Stories
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac®,...
- 841Wire Stories
Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked...
- 697Wire Stories
Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked...
- 918Wire Stories
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN, Mass. &...
- 873Wire Stories
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN, Mass. &...
- 731Wire Stories
Employers must better understand their people to improve staff retention
Employers should use staff assessments to make better-informed people decisions and improve employee retention TRUMBULL, Conn.–(BUSINESS WIRE)–#HR–Staff retention has become a key...
